Cash and cash equivalents (USD, thousands)

Marketable debt securities (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventories (USD, thousands)

Restricted cash (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Intangible assets, net (USD, thousands)

Operating lease right-of-use assets, net (USD, thousands)

Goodwill (USD, thousands)

Other non-current assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued and other current liabilities (USD, thousands)

Operating lease liabilities, current (USD, thousands)

Income taxes payable (USD, thousands)

Deferred revenue, current (USD, thousands)

Total current liabilities (USD, thousands)

Operating lease liabilities, non-current (USD, thousands)

Other long-term liabilities (USD, thousands)

Total liabilities (USD, thousands)

Ordinary shares, $ 0.00045 par value per share, 200,000,000 shares authorized; 41,963,959 and 40,520,558 shares issued and outstanding at January 31, 2025 and January 31, 2024, respectively (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive loss (USD, thousands)

Accumulated deficit (USD, thousands)

Total shareholders’ equity (USD, thousands)

Total liabilities and shareholders' equity (USD, thousands)

a20b89125dd6cbf82a72d62dd4396199bbce9f2dc0f62bf360433d1565cdb7e2

Revenue (USD, thousands)

Cost of Revenue (USD, thousands)

Gross Profit (USD, thousands)

Research and Development Expenses (USD, thousands)

Selling, General and Administrative Expenses (USD, thousands)

Total Operating Expenses (USD, thousands)

Loss from Operations (USD, thousands)

Other Income, Net (USD, thousands)

Loss Before Income Taxes (USD, thousands)

Provision (Benefit) for Income Taxes (USD, thousands)

Net Loss (USD, thousands)

521a43902fa7a8a0ba13b77cb6bba2f28baa15562256f3f8b993fc42142c7459

Taiwan

- Asia Pacific (excluding Taiwan)

Europe

- North America (excluding US)

United States

Total Revenue

df0f6c098e2bcc9eb63581e037d0c3368aaeda520b871b9ff881d121a1f6a7cd

Net loss (USD, thousands)

Depreciation and amortization (USD, thousands)

Amortization (accretion) of premium (discount) on marketable debt securities, net (USD, thousands)

Stock-based compensation (USD, thousands)

Other non-cash items, net (USD, thousands)

Net cash provided by operating activities (USD, thousands)

Purchases of investments (USD, thousands)

Sales of investments (USD, thousands)

Maturities of investments (USD, thousands)

Purchase of tangible and intangible assets (USD, thousands)

Net cash provided by (used in) investing activities (USD, thousands)

Proceeds from exercise of stock options and employee stock purchase plan (USD, thousands)

Long-term financing payment for intangible assets (USD, thousands)

Net cash provided by financing activities (USD, thousands)

Net increase (decrease) in cash, cash equivalents and restricted cash (USD, thousands)

Cash paid for income taxes (USD, thousands)

Deferred income taxes (USD, thousands)

Cash, cash equivalents and restricted cash at beginning of period (USD, thousands)

Cash, cash equivalents and restricted cash at end of period (USD, thousands)

Unpaid liabilities related to tangible and intangible assets purchases (USD, thousands)

cbdfcfa7676473691113c36867e0100fddcca9c8cf6c48a752898ddb3402c8b4

Remaining performance obligations on contracts (USD millions)

Percentage of remaining performance obligations recognized within next 12 months (percentage)

4b818a5598008d3de1029413c97a6be1b8995d56d8a36d87308020a93ed8208f

AMBARELLA (AMBA)

Financials